Explore how a landmark study is redefining cardiovascular prevention by proving that routine lipoprotein(a) [Lp(a)] testing is both cost-effective and cost-saving. Our faculty expert discusses why this biomarker represents a paradigm shift in risk assessment, challenging traditional clinical beliefs and offering a roadmap for integrating precision prevention into daily practice to better prevent heart attacks and strokes.

About Medscape Education

Medscape Education is the leading online platform for continuing medical education (CME) and continuing education (CE), trusted by millions of healthcare professionals worldwide. With more than 30 speciality-specific learning destinations, it offers thousands of free, accredited courses for physicians, nurses, pharmacists, and other healthcare professionals. Medscape Education delivers high-impact, evidence-based education designed to support clinical decision-making, improve patient outcomes, and keep healthcare professionals current in a rapidly evolving medical landscape.

Come see us at Booth #227 at ACC 2026!

Click the image below to learn more.

Rethinking Prevention – Lp(a) Testing in Cardiovascular Risk Management